Evidence Hub

Fetal Tadalafil Exposure Increases Pulmonary Blood Flow and Reduces Right to Left Heart Shunting through the Foramen Ovale

Morrison JL, Williams GK, Cho SKS, Meakin AS, Holman SL, Quinn M, Wiese MD, Macgowan CK et al.

Neonatology, 2026

9 participants

Abstract

Introduction: Fetal growth restriction (FGR) increases the risk of poor in utero, neonatal, and long-term health outcomes. Tadalafil (TAD) is the current focus of a phase II exploratory trial (TADAFER IIb) to determine its efficacy as an intervention for FGR. Herein, we aimed to determine the impact that TAD has on fetal hemodynamics.

Methods: At 116-117 days of gestational age (dGA), pregnant ewes carrying normally grown fetuses (n = 9) underwent fetal catheterization surgery before undergoing MRI scans at 119-123 dGA to measure blood flow and oxygenation within the major vessels of the fetal circulation using phase contrast MRI and T2 oximetry. Baseline measures were performed after a fetal vehicle infusion and then repeated after a fetal TAD infusion. Fetal TAD concentrations were measured by LC-MS/MS.

Results: TAD did not impact right or left ventricular (LV) output but was associated with an increase in pulmonary blood flow with reduced blood flow through both the ductus arteriosus and foramen ovale (FO). The difference in blood oxygenation between the ascending aorta and main pulmonary artery was significantly reduced, but cerebral oxygen delivery was maintained by increased carotid artery blood flow.

Conclusion: Fetal TAD exposure alters pulmonary hemodynamics and reduces the proportion of the LV preload blood pool that is made up of oxygen-rich blood from the FO. Given fetal exposure to sildenafil increases the rate of persistent pulmonary hypertension after birth…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free